Healthscope has been one of our “high conviction” buy ideas.
Brookfield Capital Partners are finalising due diligence and we expect to see their offer formalised in the coming weeks.
You're not a member! Trial today
The price gap is now closing, (all cash offer $2.44), as HSO trades at $2.40 today.
